Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.4 GBX | -1.45% | 0.00% | -20.00% |
Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
Apr. 15 | Fusion Antibodies inks commercial contract for OptiPhage library | AN |
Sales 2024 * | 1.15M 1.46M | Sales 2025 * | - | Capitalization | 3.29M 4.18M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.27M | Net income 2025 * | - | EV / Sales 2024 * | 2.86 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.23
x | P/E ratio 2025 * |
-
| Employees | 48 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.63% |
1 day | -1.45% | ||
Current month | +5.43% | ||
1 month | -10.53% | ||
3 months | -17.07% | ||
6 months | -1.45% | ||
Current year | -20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Adrian Kinkaid
CEO | Chief Executive Officer | 57 | 22-08-14 |
Stephen Smyth
DFI | Director of Finance/CFO | 49 | 23-08-23 |
Simon Douglas
CHM | Chairman | 65 | 05-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colin Walsh
BRD | Director/Board Member | 68 | 06-12-31 |
Simon Douglas
CHM | Chairman | 65 | 05-12-31 |
Richard Buick
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 3.4 | -1.45% | 337 591 |
24-05-16 | 3.45 | -1.43% | 751,624 |
24-05-15 | 3.5 | +2.94% | 742,043 |
24-05-14 | 3.4 | 0.00% | 170,448 |
24-05-13 | 3.4 | 0.00% | 478,282 |
Delayed Quote London S.E., May 17, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 4.17M | |
+32.42% | 50.85B | |
+0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.73% | 26.11B | |
-22.22% | 19.13B | |
+8.57% | 13.05B | |
+27.38% | 12.16B | |
+24.38% | 12.08B |
- Stock Market
- Equities
- FAB Stock